• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Stability of daptomycin in peritoneal dialysis solutions packaged in dual-compartment infusion bags.达托霉素在双腔输液袋包装的腹膜透析液中的稳定性。
Eur J Hosp Pharm. 2016 Jan;23(1):57-60. doi: 10.1136/ejhpharm-2015-000651. Epub 2015 Aug 20.
2
Stability of Cefepime in pH-Neutral Peritoneal Dialysis Solutions Packaged in Dual-Compartment Bags.头孢吡肟在双腔袋包装的pH中性腹膜透析液中的稳定性。
Perit Dial Int. 2016 Jul-Aug;36(4):457-9. doi: 10.3747/pdi.2015.00169.
3
Stability of Meropenem and Piperacillin/Tazobactam with Heparin in Various Peritoneal Dialysis Solutions.美罗培南和哌拉西林/他唑巴坦与肝素在不同腹膜透析液中的稳定性
Perit Dial Int. 2018 Nov-Dec;38(6):430-440. doi: 10.3747/pdi.2017.00274. Epub 2018 Jul 10.
4
Stability of the combination of ceftazidime and cephazolin in icodextrin or pH neutral peritoneal dialysis solution.头孢他啶与头孢唑林在艾考糊精或pH中性腹膜透析液中的稳定性。
Perit Dial Int. 2014 Mar-Apr;34(2):212-8. doi: 10.3747/pdi.2013.00034. Epub 2014 Jan 2.
5
Stability of ceftolozane and tazobactam in different peritoneal dialysis solutions.头孢洛扎和他唑巴坦在不同腹膜透析液中的稳定性。
Perit Dial Int. 2020 Sep;40(5):470-476. doi: 10.1177/0896860820902590. Epub 2020 Feb 13.
6
Stability of Antibiotics for Intraperitoneal Administration in Extraneal 7.5% Icodextrin Peritoneal Dialysis Bags (STAB Study).腹透液外7.5%艾考糊精腹膜透析袋中腹腔内注射用抗生素的稳定性(STAB研究)
Perit Dial Int. 2016 Jul-Aug;36(4):421-6. doi: 10.3747/pdi.2015.00062. Epub 2015 Oct 22.
7
Stability of Tigecycline in Different Types of Peritoneal Dialysis Solutions.替加环素在不同类型腹膜透析液中的稳定性
Perit Dial Int. 2016 Jul-Aug;36(4):410-4. doi: 10.3747/pdi.2015.00170. Epub 2015 Nov 2.
8
Pyridine levels in ceftazidime - peritoneal dialysis admixtures stored at body temperature.头孢他啶-腹膜透析混合液在体温下储存时的吡啶水平。
Perit Dial Int. 2020 Mar;40(2):171-178. doi: 10.1177/0896860819887636. Epub 2020 Jan 17.
9
Stability of daptomycin reconstituted vials and infusion solutions.达托霉素复溶小瓶及输液溶液的稳定性。
Eur J Hosp Pharm. 2018 Mar;25(2):107-110. doi: 10.1136/ejhpharm-2015-000784. Epub 2016 Mar 14.
10
Stability and Compatibility of Antibiotics in Peritoneal Dialysis Solutions Applied to Automated Peritoneal Dialysis in The Pediatric Population.应用于儿科人群自动腹膜透析的腹膜透析液中抗生素的稳定性和相容性
Perit Dial Int. 2016;36(6):676-679. doi: 10.3747/pdi.2015.00018. Epub 2016 May 4.

引用本文的文献

1
Stability of Daptomycin in Dextrose and Icodextrin-Based Peritoneal Dialysis Solutions.达托霉素在葡萄糖和艾考糊精基腹膜透析液中的稳定性。
Can J Infect Dis Med Microbiol. 2025 Mar 27;2025:5553355. doi: 10.1155/cjid/5553355. eCollection 2025.
2
Culture-directed antibiotics in peritoneal dialysis solutions: a systematic review focused on stability and compatibility.以文化为导向的腹膜透析液中的抗生素:一项关注稳定性和相容性的系统评价。
J Nephrol. 2023 Sep;36(7):1841-1859. doi: 10.1007/s40620-023-01716-7. Epub 2023 Aug 7.

本文引用的文献

1
Effect of glucose concentration on the stability of daptomycin in peritoneal solutions.葡萄糖浓度对达托霉素在腹膜液中稳定性的影响。
Perit Dial Int. 2013 Jul-Aug;33(4):458-61. doi: 10.3747/pdi.2012.00120.
2
Temporal trends in peritonitis rates, microbiology and outcomes: the major clinical complication of peritoneal dialysis.腹膜透析主要临床并发症腹膜炎的发生率、微生物学和结局的时间趋势。
Blood Purif. 2012;33(4):284-91. doi: 10.1159/000337377. Epub 2012 May 10.
3
Daptomycin compatibility in peritoneal dialysis solutions.达托霉素在腹膜透析液中的相容性。
Perit Dial Int. 2011 Jul-Aug;31(4):492-5. doi: 10.3747/pdi.2010.00183.
4
Peritoneal dialysis-related peritonitis caused by vancomycin-resistant Enterococcus faecium.由耐万古霉素屎肠球菌引起的腹膜透析相关性腹膜炎。
Ther Apher Dial. 2011 Feb;15(1):115-6. doi: 10.1111/j.1744-9987.2010.00852.x. Epub 2010 Aug 31.
5
Vancomycin-resistant enterococci peritonitis development after shifting from hemodialysis to peritoneal dialysis.万古霉素耐药肠球菌性腹膜炎在血液透析转为腹膜透析后发生。
Ren Fail. 2010;32(9):1121-2. doi: 10.3109/0886022X.2010.509899.
6
Peritoneal dialysis-related infections recommendations: 2010 update.腹膜透析相关感染的建议:2010年更新版
Perit Dial Int. 2010 Jul-Aug;30(4):393-423. doi: 10.3747/pdi.2010.00049.
7
Intraperitoneal daptomycin used to successfully treat vancomycin-resistant enterococcus peritonitis.腹腔内使用达托霉素成功治疗耐万古霉素肠球菌腹膜炎。
Perit Dial Int. 2009 Nov-Dec;29(6):671-3.
8
Successful use of intraperitoneal daptomycin in the treatment of vancomycin-resistant enterococcus peritonitis.腹腔内使用达托霉素成功治疗耐万古霉素肠球菌腹膜炎。
Am J Kidney Dis. 2009 Sep;54(3):538-41. doi: 10.1053/j.ajkd.2008.12.017. Epub 2009 Feb 23.
9
Intraperitoneal administration of drugs in peritoneal dialysis patients: a review of compatibility and guidance for clinical use.
Perit Dial Int. 2009 Jan-Feb;29(1):5-15.
10
Pharmacokinetics and dialysate levels of daptomycin given intravenously in a peritoneal dialysis patient.腹膜透析患者静脉注射达托霉素的药代动力学及透析液水平
Scand J Infect Dis. 2009;41(2):155-7. doi: 10.1080/00365540802613095.

达托霉素在双腔输液袋包装的腹膜透析液中的稳定性。

Stability of daptomycin in peritoneal dialysis solutions packaged in dual-compartment infusion bags.

作者信息

Ramdas Sagar, Yousaf Farzana, Shastri Madhur D, Wanandy Troy, Zaidi Syed T R, Khandagale Manish, Jose Matthew, Patel Rahul P

机构信息

Division of Pharmacy, School of Medicine, University of Tasmania, Hobart, Tasmania, Australia.

Pharmacy Department, Royal Hobart Hospital, Hobart, Tasmania, Australia.

出版信息

Eur J Hosp Pharm. 2016 Jan;23(1):57-60. doi: 10.1136/ejhpharm-2015-000651. Epub 2015 Aug 20.

DOI:10.1136/ejhpharm-2015-000651
PMID:31156816
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6451525/
Abstract

BACKGROUND

Intraperitoneal daptomycin is used for the treatment of peritoneal dialysis (PD)-associated peritonitis caused by vancomycin-resistant bacteria. This study investigated the stability of daptomycin in a pH-neutral PD solution.

METHODS

Reconstituted solution of daptomycin was added to a total of nine PD bags to obtain a concentration of 20 mg/L and stored at 1 of 3 different temperatures: 4 or 25°C for up to 168 h or 37°C for up to 48 h. Stabilities were determined by visual inspection, pH measurement and high-performance liquid chromatography.

RESULTS

Daptomycin retained more than 90% of its initial concentration for 120, 72 and 12 h at 4°C, 25°C and 37°C, respectively. No physical precipitation or pH change was observed during the study.

CONCLUSIONS

Daptomycin in a pH-neutral PD solution is physically and chemically stable for 120 and 12 h at 4°C and 37°C, respectively.

摘要

背景

腹腔内使用达托霉素用于治疗由耐万古霉素细菌引起的腹膜透析(PD)相关腹膜炎。本研究调查了达托霉素在pH值中性的腹膜透析液中的稳定性。

方法

将达托霉素复溶溶液加入总共9个腹膜透析袋中,使其浓度达到20mg/L,并在3个不同温度之一储存:4℃或25℃下储存168小时,或37℃下储存48小时。通过目视检查、pH测量和高效液相色谱法测定稳定性。

结果

达托霉素在4℃、25℃和37℃下分别在120小时、72小时和12小时内保持其初始浓度的90%以上。研究期间未观察到物理沉淀或pH值变化。

结论

pH值中性的腹膜透析液中的达托霉素在4℃和37℃下分别在物理和化学上稳定120小时和12小时。